Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

Abstract Background Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of liver metastasis arising from early gastric cancer...

詳細記述

保存先:
書誌詳細
主要な著者: Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki
フォーマット: Artigo
言語:Inglês
出版事項: Japan Surgical Society 2018-07-01
シリーズ:Surgical Case Reports
主題:
Gastric cancer
Nivolumab
Complete response
Chemotherapy
Biomarker
オンライン･アクセス:http://link.springer.com/article/10.1186/s40792-018-0479-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料